Race against time: new hope for kids with Tough-to-Treat cancer
NCT ID NCT03165292
Summary
This study aimed to find a better way to treat children with very high-risk neuroblastoma, a serious childhood cancer, when standard first treatments don't work well. It compared two different sequences of powerful chemotherapy and stem cell transplants. The goal was to see which approach helped children live longer without their cancer getting worse or coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VERY HIGH RISK NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Istituto nazionaleTumori
Milan, 20133, Italy
-
Gustave Roussy
Villejuif, Val De Marne, 94805, France
-
Hospital Universitario Cruces
Cruces, 48903, Spain
-
Hospital Universitario y policnico La Fe
Valencia, 46026, Spain
-
Medizinische Universität Innsbruck
Innsbruck, 356020, Austria
-
Meyer children's Hospita
Florence, 50139, Italy
-
Ospedale Pediatrico Bambino Gesù
Roma, Italy
-
Princess Maxima Center
Utrecht, Netherlands
-
St. Anna Kinderspital GmbH
Vienna, 1090, Austria
Conditions
Explore the condition pages connected to this study.